ADA and tuberculosis: In our study when analyzed separately no significant change was observed in levels of ADA with treatment in TB lymphadenitis patients whereas among TB pleuritis patients ADA levels significantly decreased only at 6 months of treatment indicating that biomarkers may behave differently in different manifestations of TB.